Martin VanTrieste
Martin VanTrieste is recently retired Chief Quality Officer, Amgen, and Chair of the Board of Directors, Parenteral Drug Association.
Global Vigilance
February 23, 2017
“Rx-360 was created as part of an emotional reaction to the home truth that criminals were violating our industry. My wish was to use the upwelling of strong sentiment to drive positive change.”
1 min read
Newsletters
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
